Spruce Biosciences, Inc. Common Stock, Capital Shares Reserved for Future Issuance
Spruce Biosciences, Inc. (SPRB) had Common Stock, Capital Shares Reserved for Future Issuance of 525.57 thousand shares as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Stockholders' Equity Note
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-08-12
- 2026-06-30: Common Stock, Capital Shares Reserved for Future Issuance 525.57K shares.
- 2026-03-31: Common Stock, Capital Shares Reserved for Future Issuance 445.71K shares.
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 291.01K shares.
- 2025-09-30: Common Stock, Capital Shares Reserved for Future Issuance 346.55K shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance | Common Stock, Capital Shares Reserved for Future Issuance as first filed |
|---|---|---|
| 2026-06-30 | 525.57K shares 10-Q · filed 2026-08-12 | |
| 2026-03-31 | 445.71K shares 10-Q · filed 2026-05-13 | |
| 2025-12-31 | 291.01K shares 10-Q · filed 2026-08-12 | |
| 2025-09-30 | 346.55K shares 10-Q · filed 2025-11-10 | |
| 2025-06-30 | 346.98K shares 10-Q · filed 2025-08-14 | |
| 2025-03-31 | 26.02M shares 10-Q · filed 2025-05-06 | |
| 2024-12-31 | 285.08K shares 10-K · filed 2026-03-09 | 21.38M shares 10-K · filed 2025-04-15 |
| 2024-09-30 | 23.05M shares 10-Q · filed 2024-11-12 | |
| 2024-06-30 | 23.05M shares 10-Q · filed 2024-08-12 | |
| 2024-03-31 | 23.35M shares 10-Q · filed 2024-05-13 | |
| 2023-12-31 | 21.03M shares 10-K · filed 2025-04-15 | 21.02M shares 10-K · filed 2024-03-18 |
| 2023-09-30 | 21.57M shares 10-Q · filed 2023-11-13 | |
| 2023-06-30 | 21.57M shares 10-Q · filed 2023-08-14 | |
| 2023-03-31 | 22.56M shares 10-Q · filed 2023-05-15 | |
| 2022-12-31 | 7.70M shares 10-K · filed 2024-03-18 | |
| 2022-09-30 | 7.83M shares 10-Q · filed 2022-11-10 | |
| 2022-06-30 | 7.84M shares 10-Q · filed 2022-08-10 | |
| 2022-03-31 | 8.02M shares 10-Q · filed 2022-05-11 | |
| 2021-12-31 | 5.75M shares 10-K · filed 2023-03-16 | |
| 2021-09-30 | 6.29M shares 10-Q · filed 2021-11-15 | |
| 2021-06-30 | 6.42M shares 10-Q · filed 2021-08-10 | |
| 2021-03-31 | 6.49M shares 10-Q · filed 2021-05-12 | |
| 2020-12-31 | 5.14M shares 10-K · filed 2022-03-14 | |
| 2020-09-30 | 17.94M shares 10-Q · filed 2020-11-18 | |
| 2019-12-31 | 5.19M shares 10-K · filed 2021-03-22 | 5.19M shares 10-Q · filed 2020-11-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |